MELINDA FUQUA: Open Payments
NPI 1215223151 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,208 in 96 payments from 19 companies in 2025. Trend: 2023 $2,406 · 2024 $9,028 · 2025 $5,208
Food & beverage: $2,808Speaker / faculty: $2,400
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 11 | $2,652 |
| Janssen Biotech, Inc. | 15 | $723 |
| ABBVIE INC. | 29 | $704 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $288 |
| GENZYME CORPORATION | 2 | $143 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $117 |
| Lilly USA, LLC | 6 | $116 |
| Janssen Scientific Affairs, LLC | 1 | $105 |
| Ardelyx, Inc. | 3 | $62 |
| Aimmune Therapeutics, Inc. | 2 | $52 |
Products named: VOQUEZNA, TREMFYA, RINVOQ, SKYRIZI, DUPIXENT, ENTYVIO, XIFAXAN, OMVOH.
Industry payments across IN — which companies pay providers there.
